Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03051347 · ClinicalTrials.gov registry record · NA
Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments
A NA study of Atopic Dermatitis and Psoriasis, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 943
- Enrollment target
- 1
- Study location
NCT03051347 is a NA study of Atopic Dermatitis and Psoriasis that has completed, run by Northwestern University. The registered enrollment target is 943 participants, above the 603-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (56% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03051347, a NA study of Atopic Dermatitis and Psoriasis, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 943 participants
- Enrollment target
- 1
- Study location
Study Summary
This is designated to validate patient-reported outcomes (PRO) measures in itch-specific pediatric skin conditions, such as atopic dermatitis, and examine the ability of a modified stigma instrument to assess the severity and type of stigma experienced in atopic dermatitis and other potentially stigmatizing conditions.
Conditions Studied
Interventions
- OTHER Itch Questionnaire and Interview
- OTHER Stigma Questionnaire and Interview
- OTHER Cognitive Interview and PROMIS Itch Questionnaire
Study Locations (1)
Illinois
- Department of Dermatology, Northwestern University Feinberg School of Medicine and Lurie Children's Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 943 participants |
| Start Date | 2016-09 |
| Est. Completion | 2020-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03051347
The ClinicalTrials.gov registry entry for NCT03051347 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 943 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 603-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (56% higher). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Atopic Dermatitis appearing as the primary indexed condition, and to 3 interventions - of which Itch Questionnaire and Interview is the first listed.
NCT03051347 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT03051347 about?
NCT03051347 is a clinical study titled "Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments". This is designated to validate patient-reported outcomes (PRO) measures in itch-specific pediatric skin conditions, such as atopic dermatitis, and examine the ability of a modified stigma instrument to assess the severity and type of stigma experienced in atopic dermatitis and other potentially stig...
What is the current status of trial NCT03051347?
This trial is currently completed. It is a NA study. The enrollment target is 943 participants. The study started on 2016-09. Estimated completion is 2020-06-30.
What conditions does trial NCT03051347 study?
This clinical trial studies the following conditions: Atopic Dermatitis, Psoriasis, Ichthyosis.
What interventions are being tested in trial NCT03051347?
The interventions under investigation include: Itch Questionnaire and Interview (OTHER), Stigma Questionnaire and Interview (OTHER), Cognitive Interview and PROMIS Itch Questionnaire (OTHER).
Who is sponsoring clinical trial NCT03051347?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03051347 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atopic Dermatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project
RECRUITING · NA
-
Topical Treatment for Atopic Dermatitis
RECRUITING · NA
-
Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic Dermatitis
COMPLETED · NA
-
A Study Comparing the Efficacy of Two Topical Steroid Application Regimens in Pediatric Patients With Atopic Dermatitis
COMPLETED · NA
-
Reversal of Epidermal Phenotype in Severe Atopic Dermatitis With Cyclosporine Therapy
COMPLETED · NA
-
Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.